English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cobalt(III) complexes with  N -salicylidene-2-hydroxy-5-bromobenzylamine (H 2 sbba) and  N -salicylidene-2-hydroxy-5-chlorobenzylamine (H 2 scba), [ n -(C 4 H 9 ) 4 N][Co(sbba) 2 ] ( I ) and [ n -(C 4 H 9 ) 4 N][Co(scba) 2 ] ( II ), were synthesized. The crystal structure of  II  was determined by the single-crystal X-ray diffraction method at 90 K confirming its crystallization in the monoclinic space group  P 2 1 / n  with  a  = 11.729(2) Å,  b  = 16.901(3) Å,  c  = 21.483(4) Å,  β  = 98.840(4) ˚ ,  V  = 4208.2(14) Å 3 ,  D  x  = 1.295 g cm −3 , and  Z  = 4. The  R 1 [ I  &gt; 2 σ ( I )] and  wR 2 (all data) values of 0.0664 and 0.1920, respectively, for all 9521 independent reflections. The compound is composed of a tetra(  n -butyl)ammonium cation and an octahedral cobalt(III) complex anion with two scba 2−  ligands in a meridional fashion. The electronic spectral features of  I  and  II  are consistent with the octahedral cobalt(III) ion with an N 2 O 4  donor set.

Mononuclear cobalt(III) complexes with N -salicylidene-2-hydroxy-5-bromobenzylamine and N -salicylidene-2-hydroxy-5-chlorobenzylamine ‡